RALEIGH, N.C.(WNCN) – With full approval also comes a new name for the first COVID-19 vaccine to cross the FDA finish line.
The Pfizer vaccine has gone by Pfizer, Pfizer-BioNTech, and BNT162b2 in the science community.
It will now be marketed as Comirnaty. The name is pronounced (koe-mir-na-tee).
So where did the name come from?
Pfizer announced in December the name is a combination of the words COVID-19, mRNA, community, and immunity. The company said the name was to highlight the first authorization of an mRNA vaccine and the global efforts that made it possible.
On Monday, Pfizer said it intended to submit for approval of Comirnaty in children ages 12 through 15 once there was six months’ worth of data.
Third doses for the immunocompromise and boosters for the general public will also need their own approval at a later time.
The FDA wants to see at least six months of data for those uses, too.